T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.82B |
| 2 |
Sea Limited
SE
|
+$1.38B |
| 3 |
Cisco
CSCO
|
+$1.16B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.54B |
| 2 |
Amazon
AMZN
|
+$1.75B |
| 3 |
Amphenol
APH
|
+$1.65B |
| 4 |
KLA
KLAC
|
+$1.5B |
| 5 |
Xcel Energy
XEL
|
+$1.38B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
First Busey Corp
BUSE
$2.56B
| $2.61M | ﹤0.01% |
103,430
+11,642
| +13% | +$293K |
|
1702
Monopar Therapeutics
MNPR
$731M
| $2.61M | ﹤0.01% |
47,702
+24,975
| +110% | +$1.51M |
|
1703
Kinetik
KNTK
$3.64B
| $2.61M | ﹤0.01% |
53,895
+7,503
| +16% | +$319K |
|
1704
ArcBest
ARCB
$3.33B
| $2.61M | ﹤0.01% |
26,511
+3,628
| +16% | +$344K |
|
1705
RingCentral
RNG
$4.77B
| $2.6M | ﹤0.01% |
69,912
+5,616
| +9% | +$181K |
|
1706
First Hawaiian
FHB
$3.42B
| $2.6M | ﹤0.01% |
105,407
+8,667
| +9% | +$223K |
|
1707
Takeda Pharmaceutical
TAK
$56B
| $2.6M | ﹤0.01% |
+140,193
| New | +$2.46M |
|
1708
FB Financial Corp
FBK
$2.98B
| $2.59M | ﹤0.01% |
49,820
+10,337
| +26% | +$581K |
|
1709
Enviri
NVRI
$623M
| $2.59M | ﹤0.01% |
131,854
+5,928
| +5% | +$110K |
|
1710
NETSCOUT
NTCT
$2.89B
| $2.58M | ﹤0.01% |
81,047
+10,080
| +14% | +$293K |
|
1711
Ericsson
ERIC
$32.7B
| $2.57M | ﹤0.01% |
+228,213
| New | +$2.47M |
|
1712
Graphic Packaging
GPK
$3.45B
| $2.57M | ﹤0.01% |
258,735
+16,969
| +7% | +$214K |
|
|
OMDA
1713
Omada Health Inc
OMDA
$1.21B
| $2.57M | ﹤0.01% |
204,412
-10,096
| -5% | -$139K |
|
1714
Western Union
WU
$2.58B
| $2.57M | ﹤0.01% |
294,038
+24,603
| +9% | +$233K |
|
1715
Banc of California
BANC
$3.27B
| $2.56M | ﹤0.01% |
145,686
+24,930
| +21% | +$476K |
|
|
DAWN
1716
DELISTED
Day One Biopharmaceuticals
DAWN
| $2.56M | ﹤0.01% |
119,288
+16,832
| +16% | +$237K |
|
1717
National Vision
EYE
$1.75B
| $2.54M | ﹤0.01% |
98,241
+10,382
| +12% | +$282K |
|
1718
Knowles
KN
$3.07B
| $2.54M | ﹤0.01% |
99,091
+15,968
| +19% | +$404K |
|
1719
InvenTrust Properties
IVT
$2.81B
| $2.53M | ﹤0.01% |
83,070
+16,540
| +25% | +$498K |
|
1720
Upstart Holdings
UPST
$2.66B
| $2.5M | ﹤0.01% |
97,604
+17,225
| +21% | +$606K |
|
1721
Syndax Pharmaceuticals
SNDX
$1.74B
| $2.5M | ﹤0.01% |
107,133
+12,304
| +13% | +$267K |
|
1722
ABM Industries
ABM
$2.88B
| $2.49M | ﹤0.01% |
64,724
+8,900
| +16% | +$385K |
|
|
GTY
1723
Getty Realty Corp
GTY
$2.12B
| $2.49M | ﹤0.01% |
78,232
+11,972
| +18% | +$374K |
|
1724
CleanSpark
CLSK
$3.46B
| $2.47M | ﹤0.01% |
289,702
+23,172
| +9% | +$248K |
|
1725
National Bank Holdings
NBHC
$1.9B
| $2.47M | ﹤0.01% |
62,948
+6,082
| +11% | +$244K |
|
Similar funds
T. Rowe Price Associates's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
- T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
- T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
- T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
- T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.